These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 6322566
1. Regression of left ventricular hypertrophy from systemic hypertension by enalapril. Nakashima Y, Fouad FM, Tarazi RC. Am J Cardiol; 1984 Apr 01; 53(8):1044-9. PubMed ID: 6322566 [Abstract] [Full Text] [Related]
3. Effect of enalapril on left ventricular mass and performance in essential hypertension. Grandi AM, Venco A, Barzizza F, Casadei B, Marchesi E, Finardi G. Am J Cardiol; 1989 May 01; 63(15):1093-7. PubMed ID: 2539714 [Abstract] [Full Text] [Related]
5. Cardiac function in systemic hypertension before and after reversal of left ventricular hypertrophy. Trimarco B, De Luca N, Ricciardelli B, Rosiello G, Volpe M, Condorelli G, Lembo G, Condorelli M. Am J Cardiol; 1988 Oct 01; 62(10 Pt 1):745-50. PubMed ID: 2971309 [Abstract] [Full Text] [Related]
6. [Regression of hypertensive heart hypertrophy caused by chronic angiotensin-converting enzyme inhibition]. Motz W, Strauer BE. Z Kardiol; 1988 Jan 01; 77(1):53-60. PubMed ID: 2834885 [Abstract] [Full Text] [Related]
8. Effects of enalapril on left ventricular mass and diastolic function in essential hypertension: special reference to duration of hypertension. Oki T, Fukuda N, Iuchi A, Tabata T, Sasaki M, Kawahara K, Ishimoto T, Tominaga T, Okushi H, Fujimoto T, Ito S. J Card Fail; 1995 Dec 01; 1(5):365-70. PubMed ID: 12836711 [Abstract] [Full Text] [Related]
10. The effects of long-term treatment on left ventricular hypertrophy in patients with essential hypertension: relation to changes in neurohumoral factors. Ueno H, Takata M, Tomita S, Oh-hashi S, Yasumoto K, Inoue H. J Cardiovasc Pharmacol; 1997 Nov 01; 30(5):643-8. PubMed ID: 9388047 [Abstract] [Full Text] [Related]
11. Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. Dunn FG, Oigman W, Ventura HO, Messerli FH, Kobrin I, Frohlich ED. Am J Cardiol; 1984 Jan 01; 53(1):105-8. PubMed ID: 6318542 [Abstract] [Full Text] [Related]
13. Effects of antihypertensive treatment on cardiac hypertrophy and cardiac function in elderly hypertensive patients. Nagano N, Iwatsubo H, Hata T, Mikami H, Ogihara T. J Cardiovasc Pharmacol; 1991 Jan 01; 17 Suppl 2():S163-5. PubMed ID: 1715472 [Abstract] [Full Text] [Related]
15. Preserved ventricular pump function after a marked reduction of left ventricular mass. Ketelhut R, Franz IW, Behr U, Toennesmann U, Messerli FH. J Am Coll Cardiol; 1992 Oct 01; 20(4):864-8. PubMed ID: 1356116 [Abstract] [Full Text] [Related]
17. Hemodynamic and antihypertensive effects of the new oral angiotensin-converting-enzyme inhibitor MK-421 (enalapril). Fouad FM, Tarazi RC, Bravo EL, Textor SC. Hypertension; 1984 Oct 01; 6(2 Pt 1):167-74. PubMed ID: 6327515 [Abstract] [Full Text] [Related]
18. [Hypertensive hypertrophy of the left ventricle: its regression in hypertensive patients with different profiles of plasma renin activity, treated with enalapril]. Nogueira JB, Soares Ade O, da Costa JN. Rev Port Cardiol; 1990 Jun 01; 9(6):511-6. PubMed ID: 2147377 [Abstract] [Full Text] [Related]